Lumenis Australia is offering significant financial incentives to eye health professionals who invest in Optima M22 IPL in an effort to provide support through COVID-19.
Approved purchasers who have the Optima M22 IPL installed and in use in practice by 31 December 2020 can take advantage of 12 months interest free finance with no repayments for 12 months. Additionally, they can take advantage of the Government’s AU$150k instant asset write off.
Approved purchasers who have the Optima M22 IPL installed and in use in practice by 31 December 2020 can take advantage of 12 months interest free finance with no repayments for 12 months
“As the National COVID Committee continues to implement the phased system of operation for medical and cosmetic procedures, Lumenis Australia is here to do our part in ensuring your return is as seamless and successful as possible,” said Tracey Cannon, ANZ Marketing Director at Lumenis Australia.
“Our goal, as it has always been, is to stand beside you and offer a helping hand and partner with you, as your business builds. This Optima M22 IPL offer allows you to access new equipment, expand your treatment offering and increase revenue potential – while providing you the opportunity to better establish your business during these difficult times without having to experience the financial burden right now.”
The Optma M22 IPL comes with a two-year manufacturer warranty. Terms and conditions apply to the offer.
Contact: (AUS) 1800 586 364 or email [email protected].
